For Research Use OnlyGLP2 T
GLP2 T is a synthetic dual receptor agonist, engineered to engage two incretin receptors rather than one, with the multi-receptor design an explicit intention before the molecule existed. Supplied lyophilised at 10mg for $70 or 20mg for $120 — $7.00 and $6.00 per mg respectively. Because the targets were known in advance, its evidence base is hypothesis-driven and organised around endpoints chosen before data was collected. A dual agonist can also be compared meaningfully against other members of its class, since receptor engagement is measurable and transfers between laboratories. It is a long synthesis, so read the trace for peaks adjacent to the product. Research use only.
Transparency
Certificate of Analysis
Every batch independently verified by third-party laboratories.
GLP2 T COA
All Proxiva Peptides products are independently tested by accredited third-party laboratories. Results are batch-specific and provided for research transparency only. This product is not approved for human use.
Lab Verified
Every Dose, Independently Tested
Verified by Vanguard Laboratory — always ≥99.5% purity, tested 7×. Swipe to view your selected dose.
Support
Frequently Asked Questions
Everything you need to know about this product and your order.
Scientific References
Explore the published research literature on GLP2 T. We link directly to independent, primary sources — we don't summarize or interpret findings. For research use only.
Links open external databases (pubmed.ncbi.nlm.nih.gov · clinicaltrials.gov). Proxiva Peptides is not affiliated with these sources. For research use only — not medical advice.
Certificate of Analysis
GLP2 T · ≥99.4% purity (HPLC)